Martínez-Luna E, Bologna-Molina R, Mosqueda-Taylor A, Cuevas-González JC, Rodríguez-Lobato E, Martínez-Velasco MA, Vega-Memíje ME. Inmunohistochemical detection of mastocytes in tissue from patients with actinic prurigo. J Clin Exp Dent. 2015;7(5):e656-9.

doi:10.4317/jced.52823

http://dx.doi.org/doi:10.4317/jced.52823

References

1. Granados J, Domínguez L. Inmunogenética del prúrigo actínico en mexicanos. Dermatol Rev Mex. 1993;37:314-5.

2. Dawe RS, Collins P, Ferguson J, O"Sullivan A. Actinic prurigo and HLA-DR4. J Invest Dermatol. 1997;108:233-4.
http://dx.doi.org/10.1111/1523-1747.ep12335344
PMid:9008241

3. Hojyo T, Granados J, Vargas G, Yamamoto JK, Vega ME, Cortés R, et al. Further evidence of the role of HLA-DR4 in the genetic susceptibility to actinic prurigo. J Am Acad Dermatol. 1997;36:935-7.
http://dx.doi.org/10.1016/S0190-9622(97)80276-9

PMid:9204058

4. Wiseman MC, Orr PH, Macdonald SM, Schroeder ML, Toole JW. Actinic prurigo: clinical features and HLA associations in a Canadian Inuit population. J Am Acad Dermatol. 2001;44:952-6.
http://dx.doi.org/10.1067/mjd.2001.112579
PMid:11369906

5. Menagé H, Vaughan RW, Baker CS, Page G, Proby CM, Breathnach SM, et al. HLA-DR4 may determine expression of actinic prurigo in British patients. J Invest Dermatol. 1996;106:362-7.
http://dx.doi.org/10.1111/1523-1747.ep12343141

PMid:8601742

6. Durán M. Prúrigo actínico. Estudios de HLA. Antígenos de linfocitos humanos. Respuesta inmune celular. Dermatol Rev Mex. 1993;37:316.

7. Hojyo T, Vega E, Granados J, Flores O, Cortés R, Teixeira F, et al. Actinic prurigo: an update. Int J Dermatol. 1995;34:380-4.
http://dx.doi.org/10.1111/j.1365-4362.1995.tb04435.x

PMid:7657433

8. Domínguez L. Prurigo Actínico. Historia y situación actual. Dermatol Rev Mex. 1993;37:292.

9. Novales J. Prurigo actínico. Características clínicas. Dermatol Rev Mex. 1993;37:293-4.

10. Magaña M. Actinic or solar prurigo. J Am Acad Dermatol. 1997;36:504-5.
http://dx.doi.org/10.1016/S0190-9622(97)80256-3

PMid:9091504

11. Lane PR, Hogan DJ, Martel MJ, Reeder B, Irvine J. Actinic prurigo: clinical features and prognosis. J Am Acad Dermatol. 1992; 26:683-92.
http://dx.doi.org/10.1016/0190-9622(92)70093-U

PMid:1583166

12. Vega-Memije ME, Mosqueda-Taylor A, Irigoyen-Camacho ME, Hojyo-Tomoka MT, Domínguez-Soto L. Actinic prurigo cheilitis: clinicopathologic analysis and therapeutic results in 116 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002;94:83-91.
http://dx.doi.org/10.1067/moe.2002.123539

PMid: 12193899

13. Hojyo MT. Prurigo actinico. Diagnóstico diferencial. Dermatol Rev Mex. 1993;37:303.

14. Vega ME, Ortega S, Hojyo MT, Reyes MM. Queilitis. Correlación clínico-patológica. Dermatol Rev Mex. 1991;35:212-7.

15. Herrera R, Magaña M. Follicular cheilitis. A distinctive histopathologic finding in actinic prurigo. Am J Dermatopathol. 1995;17:357-61.

PMid:8600799

16. Arrese JE, Domínguez L, Hojyo MT, Vega E, Cortés R, Guevara E, et al. Effectors of inflammation in actinic prurigo. J Am Acad Dermatol. 2001;44:957-61.
http://dx.doi.org/10.1067/mjd.2001.113477
PMid:11369907

17. Pizzi N. Aspectos menos conocidos del Prurigo actínico. Dermatol Rev Mex. 1993;37:298.

18. Hojyo MT, Domínguez L, Maga-a M. Phototesting in actinic prurigo. Volume of abstracts I; 17th World Congress of Dermatology; Berlin. 1987:305-6.

19. Hojyo MT. Pruebas fotobiológicas en Prurigo actínico. Dermatol Rev Mex. 1993;37:326-7.

20. Johnson JA, Fusaro RM. Photosensitivity of the American Indian: Terminology and historical aspects. J Am Acad Dermatol. 1998;39:662-4.
http://dx.doi.org/10.1016/S0190-9622(98)70030-1

PMid:9777787

21. McGregor JM, Grabczynska S, Vaughan R, Hawk JL, Lewis CM. Genetic modeling of abnormal photosensitivity in families with polymorphic light eruption and actinic prurigo. J Invest Dermatol. 2000;115:471-6.
http://dx.doi.org/10.1046/j.1523-1747.2000.00080.x
PMid:10951286

22. Epstein J. La fotobiología del prurigo actínico. Dermatol Rev Mex. 1993;37:321-4.

23. Ávalos E, Ramírez R, Vega ME. ¿Es la luz ultravioleta el factor que desencadena la proliferación linfocitaria en la piel de los pacientes con Prurigo actínico?. Dermatol Rev Mex. 1993;37:308-11.

24. Ávalos E, Ramírez R, Presno M. Subpoblaciones de linfocitos T en pacientes con Prurigo actínico. Dermatol Rev Mex. 1993;37:305-7.

25. Miyachi Y. Reactive oxigen species in photodermatology. Photochem Photobiol. 1987;46:213-21.

26. Miyazaki D, Nakamura T, Toda M, Cheung-Chau KW, Richardson RM, Ono SJ. Macrophage inflammatory protein-1alpha as a costimulatory signal for mast cell-mediated immediate hypersensitivity reactions. J Clin Invest. 2005;115:434-42.
http://dx.doi.org/10.1172/JCI18452
PMid:15650768 PMCid:PMC544033

27. Fischer M, Harvima IT, Carvahlo RF, Moller C, Naukkarinen A, Enblad G, et al. Mast cell CD30 ligand is upregulated in cutaneous inflammation and mediates degranulation-independent chemokine secretion. J Clin Invest. 2006;116:2748-56.
http://dx.doi.org/10.1172/JCI24274
PMid:16964309 PMCid:PMC1560346

28. Atkins SR, Matteson EL, Myers J, Ryu JH, Bongartz T. Morphological and quantitative assessment of mast cells in rheumatoid arthritis associated non-specific interstitial pneumonia and usual interstitial pneumonia. Ann Rheum Dis. 2006;65:677-80.
http://dx.doi.org/10.1136/ard.2005.043877
PMid:16611865 PMCid:PMC1798120

29. Kanbe N, Tanaka A, Kanbe M, Itakura A, Kurosawa M, Matsuda H. Human mast cells produce matrix metalloproteinase 9. Eur J Immunol. 1999;29:2645-9.
http://dx.doi.org/10.1002/(SICI)1521-4141(199908)29:08<2645::AID-IMMU2645>3.0.CO;2-1

PMid:10458779

30. Chvatchko Y, Kosco MH, Herren S, Lefort J, Bonnefoy JY. Germinal center formation and local immunoglobulin E (IgE) production in the lung after an airway antigenic challenge. J Exp Med. 1996;184:2353-60.
http://dx.doi.org/10.1084/jem.184.6.2353
PMid:8976189 PMCid:PMC2196373

31. Coombs & Gell . Classification of allergic reactions responsible for clinical hypersensitivity and disease. In: Clinical Aspects of Immnunology. 1a Ed; Oxford: University Press, 1968:575-96.

32. Warrington R, Silviu-Dan F. Drug allergy. Allergy Asthma Clin Immunol. 2011;7:1492-7.
http://dx.doi.org/10.1186/1710-1492-7-S1-S10
PMid:22165859 PMCid:PMC3245433

33. Pichler WJ. Delayed drug hypersensitivity reactions. Ann Intern Med. 2003;139:683-93.
http://dx.doi.org/10.7326/0003-4819-139-8-200310210-00012
PMid:14568857

34. Adam J, Pichler WJ, Yerly D. Delayed drug hypersensitivity: models of T-cell stimulation. Br J Clin Pharmacol. 2011;5:701-7.
http://dx.doi.org/10.1111/j.1365-2125.2010.03764.x
PMid:21480949 PMCid:PMC3093075

35. Yu M, Tsai M, Tam S, Jones C, Zehnder J, Galli SJ. Mast cells can promote the development of multiple features of chronic asthma in mice. J Clin Invest. 2006;116:1633-41.
http://dx.doi.org/10.1172/JCI25702
PMid:16710480 PMCid:PMC1462940

36. Abbas AK, Lichtman AH. Cellular and Molecular Immunology. 5a ed; Elsevier, 2004:432-52.

37. Adam J, Pichler W, Yerly D. Delayed drug hypersensitivity: models of T-cell stimulation. Br J Clin Pharmacol. 2011;71:701-7.
http://dx.doi.org/10.1111/j.1365-2125.2010.03764.x
PMid:21480949 PMCid:PMC3093075

38. Vega ME. Características histopatológicas de Prurigo actínico. Dermatol Rev Mex. 1993;37:295-7.

39. Janssens AS, Heide R, Hollander JC, Mulder PG, Tank B, Oranje AP. Mast cell distribution in normal adult skin. J Clin Pathol. 2005;58:285-9.
http://dx.doi.org/10.1136/jcp.2004.017210
PMid:15735162 PMCid:PMC1770584

40. Moncada B, González R, Baranda ML, Loredo C, Urbina R. Immunopathology of polymorphous light eruption. T lymphocytes in blood and skin. J Am Acad Dermatol 1984;10:970-3.
http://dx.doi.org/10.1016/S0190-9622(84)80316-3

PMid:6234329

41. Umaña A, Gómez A, Durán MM, Porras L. Lymphocyte subtypes and adhesion molecules in actinic prurigo: observations with cyclosporin A. Int J Dermatol. 2002;41:139-45.
http://dx.doi.org/10.1046/j.1365-4362.2002.01419.x

PMid:12010338